Results 181 to 190 of about 305,336 (311)

Detecting Incipient Heart Failure in Asymptomatic Patients with Normal Ejection Fraction and comparisons with patients with heart failure and preserved ejection fraction using TimeSformer for classifying Echocardiography videos [PDF]

Srilakshmi M. Adhyapak, Prahlad G. Menon
openalex   +1 more source

Role of spin echo and cine magnetic resonance imaging in presurgical planning of heterotaxy syndrome. Comparison with echocardiography and catheterization. [PDF]

, 1994
Tal Geva, G. Wesley Vick, Richard E. Wendt, Roxann Rokey   +3 more
openalex   +1 more source

Evaluation of hemodynamic changes during laparoscopic cholecystectomy by transthoracic echocardiography

, 2021
Arnab Banerjee, Savita Saini, Jatin Lal
openalex   +1 more source

Mortality risk stratification for Takotsubo syndrome: Evaluating CRP measurement alongside the InterTAK prognostic score

ESC Heart Failure, Volume 12, Issue 2, Page 1427-1436, April 2025.
Abstract Background and objectives Initially described as a benign acute cardiomyopathy, Takotsubo syndrome has been linked to elevated mortality rates. Emerging evidence suggests that unresolved myocardial inflammation may contribute to this adverse prognosis.
Loïc Faucher, Kensuke Matsushita, Shinnosuke Kikuchi, Taraneh Tatarcheh, Benjamin Marchandot, Amandine Granier, Said Amissi, Antonin Trimaille, Laurence Jesel, Patrick Ohlmann, Kiyoshi Hibi, Valérie Schini‐Kerth, Olivier Morel   +12 more
wiley   +1 more source

Post-COVID-19 era heart failure diagnosis and outcomes: adherence to National Institute for Health and Care Excellence Guidelines. [PDF]

Open Heart
Razzaq UB, Docherty KF, Al Ajmi A, Alebraheem A, Burns R, Davie AP, Gan J, Hogg KJ, Jackson CE, Mathioudaki E, Pasupulate R, Piya S, Ritchie L, Simpson J, Steel LC, Wei HN, McMurray JJ, Petrie MC, Campbell RT.   +18 more
europepmc   +1 more source

Cilostazol in patients with heart failure and preserved ejection fraction—The CLIP‐HFpEF trial

ESC Heart Failure, Volume 12, Issue 2, Page 1437-1446, April 2025.
• Cilostazol is an oral PDE‐3 inhibitor that may have advantageous effects in heart failure with preserved ejection fraction (HFpEF). • Cilostazol significantly improved short‐term heart failure‐related health status scores (KCCQ‐12) and NT‐proBNP levels when compared to placebo.
Norman Aiad, Jeanne du Fay de Lavallaz, Michael J. Zhang, Thanat Chaikijurajai, Bo Ye, Prabhjot S. Nijjar, Julie A. Lahiri, Cindy M. Martin, Tamas Alexy, Markus Meyer   +9 more
wiley   +1 more source

Multimodal diagnostic imaging for early mitral valve disease: integration of current and emerging modalities-a narrative review. [PDF]

Cardiovasc Diagn Ther
AlRahimi JS.
europepmc   +1 more source

A study on referral pattern for fetal echocardiography and identifying the various risk factors for congenital heart defects

Saima Zehra
openalex   +1 more source

Sudden unexpected death in epilepsy (SUDEP): Risk management of pediatric patients with epilepsy

Epilepsia Open, EarlyView.
Abstract Objective Sudden unexpected death in epilepsy (SUDEP) is the leading cause of death in people with epilepsy with an incidence of 1:1000. The primary risk factors for SUDEP are generalized or focal to bilateral tonic–clonic seizures. Preventive measures like nighttime monitoring devices and resuscitation training address modifiable risk factors.
Laura Lutz, Lena Luise Becker, Alwina Koch, Angela M. Kaindl   +3 more
wiley   +1 more source

Diagnostic Performance of Cardiac CT and Transthoracic Echocardiography in Congenital Heart Disease: A Surgical Correlation Study. [PDF]

Diagnostics (Basel)
Bakhshaliyev S, Arslanoğlu E, Huseynov H, İnce D, Aliyev B, Yiğit F, Polat B, Zeybek C.   +7 more
europepmc   +1 more source